AbCellera Biologics Inc.: cash_and_equivalents
| Value | {"unit": "CAD", "value": 8200000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c342c328-7135-4800-bef5-f6d71b7a2c84
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-22-007077Retrieved: 2026-08-19T17:26:08.451112+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/cash-and-equivalents/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c342c328-7135-4800-bef5-f6d71b7a2c84
History
- supersedes {"amount": 476142000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001564590-22-007077)